{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:59:43Z","timestamp":1785196783528,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,5]],"date-time":"2027-05-05T00:00:00Z","timestamp":1809475200000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.japh.2026.103078","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:25:49Z","timestamp":1774023949000},"page":"103078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving pharmacy-based HPV vaccine delivery through communication training: Findings from a pilot feasibility study"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3536-6219","authenticated-orcid":false,"given":"Parth D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-6050","authenticated-orcid":false,"given":"Jennifer L.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Calo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Glascock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Watabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.japh.2026.103078_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers - United States, 2012-2016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.japh.2026.103078_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.15585\/mmwr.mm7333a1","article-title":"National vaccination coverage among adolescents aged 13-17 years - national immunization survey-teen, United States, 2023","volume":"73","author":"Pingali","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"30","key":"10.1016\/j.japh.2026.103078_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination coverage among adolescents aged 13\u201317 years \u2014 national immunization survey-teen, United States, 2024","volume":"74","author":"Pingali","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.japh.2026.103078_bib5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib6","article-title":"Role of independent versus chain pharmacies in providing pharmacy access: a nationwide, individual-level geographic information systems analysis","volume":"1","author":"Hernandez","year":"2023","journal-title":"Health Aff Sch"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/003335491613100106","article-title":"Overcoming barriers to low HPV vaccine uptake in the United States: recommendations from the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 9, 2015","volume":"131","year":"2016","journal-title":"Public Health Rep"},{"issue":"13","key":"10.1016\/j.japh.2026.103078_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm7313a2","article-title":"Federal retail pharmacy program contributions to bivalent mRNA COVID-19 vaccinations across sociodemographic characteristics - United States, September 1, 2022-September 30, 2023","volume":"73","author":"El Kalach","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib12","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.sapharm.2020.04.002","article-title":"Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond","volume":"17","author":"Aruru","year":"2021","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.japh.2022.10.008","article-title":"Parents' intention to have their child vaccinated at a community pharmacy: a national cross-sectional survey","volume":"63","author":"Varisco","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.japh.2026.103078_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1158\/1055-9965.EPI-18-0380","article-title":"Support for pharmacist-provided HPV vaccination: national surveys of U.S. physicians and parents","volume":"27","author":"Shah","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7-8","key":"10.1016\/j.japh.2026.103078_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/21645515.2019.1602433","article-title":"Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states","volume":"15","author":"Calo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib16","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1186\/s12889-023-16601-y","article-title":"Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review","volume":"23","author":"Chadi","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.japh.2026.103078_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pvr.2016.12.003","article-title":"Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: a qualitative study in Alabama","volume":"3","author":"Westrick","year":"2017","journal-title":"Papillomavirus Res"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s43058-025-00711-2","article-title":"Barriers and facilitators to HPV vaccination in rural South Carolina pharmacies: a qualitative investigation","volume":"6","author":"Davies","year":"2025","journal-title":"Implement Sci Commun"},{"issue":"3","key":"10.1016\/j.japh.2026.103078_bib19","first-page":"45","article-title":"Pharmacists' attitudes and perceived barriers to human papillomavirus (HPV) vaccination services","volume":"5","author":"Hastings","year":"2017","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1764","article-title":"Announcements versus conversations to improve HPV vaccination coverage: a randomized trial","volume":"139","author":"Brewer","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13012-018-0743-8","article-title":"Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation","volume":"13","author":"Malo","year":"2018","journal-title":"Implement Sci"},{"issue":"9","key":"10.1016\/j.japh.2026.103078_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamapediatrics.2021.0766","article-title":"Effect of training pediatric clinicians in human papillomavirus communication strategies on human papillomavirus vaccination rates: a cluster randomized clinical trial","volume":"175","author":"Szilagyi","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.japh.2026.103078_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.0016","article-title":"Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial","volume":"172","author":"Dempsey","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"45","key":"10.1016\/j.japh.2026.103078_bib24","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1016\/j.vaccine.2017.09.039","article-title":"Using the 4 PillarsTM Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination","volume":"35","author":"Zimmerman","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2163807","article-title":"Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: success stories from two private pediatric clinics","volume":"19","author":"Zorn","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.japh.2021.09.016","article-title":"The role of pharmacy technicians in vaccination services: a scoping review","volume":"62","author":"DeMarco","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2026.103078_bib27","article-title":"Vaccine administration by pharmacy technicians: impact on vaccination volume, pharmacy workflow and job satisfaction","volume":"13","author":"Miran","year":"2024","journal-title":"Exploratory Res Clin Social Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102257","article-title":"Empowering pharmacy technicians as vaccine champions: a pilot study in independent community pharmacies","volume":"65","author":"Hursman","year":"2025","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2026.103078_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2025.102429","article-title":"Leading vaccine gap closure with community health workers: the CPESN Missouri health equity approach","volume":"65","author":"Patterson","year":"2025","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2026.103078_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0749-3797(02)00415-4","article-title":"Evaluating primary care behavioral counseling interventions: an evidence-based approach","volume":"22","author":"Whitlock","year":"2002","journal-title":"Am J Prev Med"},{"issue":"2 Suppl","key":"10.1016\/j.japh.2026.103078_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amepre.2004.04.023","article-title":"Planning Committee of the addressing multiple behavioral risk factors in primary care project. Multiple behavioral risk factor interventions in primary care. Summary of research evidence","volume":"27","author":"Goldstein","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.japh.2026.103078_bib33","author":"Brewer"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2216117","article-title":"How to make effective HPV vaccine recommendations starting at age 9","volume":"19","author":"Brewer","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.japh.2026.103078_bib36","series-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","article-title":"Immunization strategies for healthcare practices and providers","author":"Bjork","year":"2021"},{"issue":"4","key":"10.1016\/j.japh.2026.103078_bib37","first-page":"28","article-title":"The role of the pharmacist in overcoming vaccine hesitancy","volume":"45","author":"Terrie","year":"2021","journal-title":"US Pharmacist"},{"key":"10.1016\/j.japh.2026.103078_bib38","author":"Shah"},{"key":"10.1016\/j.japh.2026.103078_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ypmed.2018.01.002","article-title":"Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists","volume":"109","author":"Shah","year":"2018","journal-title":"Prev Med"},{"key":"10.1016\/j.japh.2026.103078_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ypmed.2017.02.003","article-title":"Parents' willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy","volume":"99","author":"Calo","year":"2017","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.sapharm.2010.05.001","article-title":"Development of a scale to measure pharmacists' self-efficacy in performing medication therapy management services","volume":"6","author":"Martin","year":"2010","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the theoretical domains framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement Sci"},{"issue":"9","key":"10.1016\/j.japh.2026.103078_bib45","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.sapharm.2021.01.001","article-title":"Measuring implementation of medication optimization services: development and validation of an implementation outcomes questionnaire","volume":"17","author":"Livet","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1158\/1055-9965.EPI-23-0763","article-title":"Patient willingness to use a pharmacy-based colorectal cancer screening service: a national survey of U.S. adults","volume":"33","author":"Shah","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.japh.2026.103078_bib47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0306-4603(02)00300-3","article-title":"Diffusion of preventive innovations","volume":"27","author":"Rogers","year":"2002","journal-title":"Addict Behav"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated consolidated framework for implementation research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"issue":"7","key":"10.1016\/j.japh.2026.103078_bib49","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.acap.2021.05.018","article-title":"Impact of a multilevel quality improvement intervention using national partnerships on human papillomavirus vaccination rates","volume":"21","author":"Perkins","year":"2021","journal-title":"Acad Pediatr"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib50","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1542\/peds.2013-4257","article-title":"Increasing provision of adolescent vaccines in primary care: a randomized controlled trial","volume":"134","author":"Gilkey","year":"2014","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.japh.2026.103078_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.acap.2025.102870","article-title":"Impact of interventions to improve human papillomavirus vaccine uptake on other vaccines due: a secondary analysis of a randomized trial","volume":"25","author":"Jacobson","year":"2025","journal-title":"Acad Pediatr"},{"issue":"4","key":"10.1016\/j.japh.2026.103078_bib52","article-title":"Online decision support for implementing evidence-based HPV vaccination strategies in Texas safety-net pediatric clinics: impact on HPV, MCV, and Tdap initiation","volume":"14","author":"Shegog","year":"2026","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"10.1016\/j.japh.2026.103078_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1055-9965.EPI-15-0574","article-title":"Summer peaks in uptake of human papillomavirus and other adolescent vaccines in the United States","volume":"25","author":"Moss","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.japh.2026.103078_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70761","article-title":"An ecological analysis of HPV vaccination in the United States before and during the COVID-19 pandemic by age, sex, and urbanicity using private insurance claims data","volume":"14","author":"Vu","year":"2025","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib56","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-068145","article-title":"A bundled, practice-based intervention to increase HPV vaccination","volume":"155","author":"Szilagyi","year":"2025","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.japh.2026.103078_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amepre.2016.07.029","article-title":"Use of immunization information systems in primary care","volume":"52","author":"Kempe","year":"2017","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.japh.2026.103078_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PHH.0000000000000069","article-title":"Immunization information systems to increase vaccination rates: a community guide systematic review","volume":"21","author":"Groom","year":"2015","journal-title":"J Public Health Manag Pract"},{"issue":"12","key":"10.1016\/j.japh.2026.103078_bib59","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.2105\/AJPH.2014.302230","article-title":"The Texas Children's Hospital immunization forecaster: conceptualization to implementation","volume":"104","author":"Cunningham","year":"2014","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"Npj Digit Med"},{"issue":"5","key":"10.1016\/j.japh.2026.103078_bib62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/03054985.2012.731208","article-title":"Single group, pre- and post-test research designs: some methodological concerns","volume":"38","author":"Marsden","year":"2012","journal-title":"Oxford Rev Educ"},{"issue":"1","key":"10.1016\/j.japh.2026.103078_bib63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12874-019-0868-8","article-title":"Effectiveness of incentives and follow-up on increasing survey response rates and participation in field studies","volume":"19","author":"Smith","year":"2019","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:30:08Z","timestamp":1785195008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1544319126000634"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103078","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving pharmacy-based HPV vaccine delivery through communication training: Findings from a pilot feasibility study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103078"}}